These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19741189)

  • 1. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.
    Orban T; Sosenko JM; Cuthbertson D; Krischer JP; Skyler JS; Jackson R; Yu L; Palmer JP; Schatz D; Eisenbarth G;
    Diabetes Care; 2009 Dec; 32(12):2269-74. PubMed ID: 19741189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients.
    Park Y; Lee H; Takino H; Abiru N; Kawasaki E; Eisenbarth GS
    Acta Diabetol; 2001; 38(1):51-6. PubMed ID: 11487177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.
    Krischer JP; Cuthbertson DD; Yu L; Orban T; Maclaren N; Jackson R; Winter WE; Schatz DA; Palmer JP; Eisenbarth GS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):103-8. PubMed ID: 12519837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA; Rabin DU; Rowley MJ
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood.
    Vehik K; Haller MJ; Beam CA; Schatz DA; Wherrett DK; Sosenko JM; Krischer JP;
    Diabetes Care; 2011 Feb; 34(2):358-62. PubMed ID: 21270193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
    Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
    J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of autoantibodies in the TrialNet Natural History Study.
    Vehik K; Beam CA; Mahon JL; Schatz DA; Haller MJ; Sosenko JM; Skyler JS; Krischer JP;
    Diabetes Care; 2011 Sep; 34(9):1897-901. PubMed ID: 21750277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
    Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
    JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study.
    LaGasse JM; Brantley MS; Leech NJ; Rowe RE; Monks S; Palmer JP; Nepom GT; McCulloch DK; Hagopian WA;
    Diabetes Care; 2002 Mar; 25(3):505-11. PubMed ID: 11874938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening.
    Sera Y; Kawasaki E; Abiru N; Ozaki M; Abe T; Takino H; Kondo H; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S; Uchigata Y; Matsuura N; Eguchi K
    J Autoimmun; 1999 Sep; 13(2):257-65. PubMed ID: 10479394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
    Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
    Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
    Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
    Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
    Yu L; Cuthbertson DD; Maclaren N; Jackson R; Palmer JP; Orban T; Eisenbarth GS; Krischer JP;
    Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
    Knip M; Karjalainen J; Akerblom HK
    Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
    Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroconversion to islet autoantibodies between early pregnancy and delivery in non-diabetic mothers.
    Lindehammer SR; Hansson I; Midberg B; Ivarsson SA; Lynch KF; Dillner J; Lernmark A;
    J Reprod Immunol; 2011 Jan; 88(1):72-9. PubMed ID: 21111487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.
    Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W
    Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.